BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 37233460)

  • 1. Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges.
    Tramontano C; De Stefano L; Rea I
    Mar Drugs; 2023 Apr; 21(5):. PubMed ID: 37233460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles: Attractive tools to treat colorectal cancer.
    Younis NK; Roumieh R; Bassil EP; Ghoubaira JA; Kobeissy F; Eid AH
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1-13. PubMed ID: 36028154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
    Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnologies for the treatment of colon cancer: From old drugs to new hope.
    Kotelevets L; Chastre E; Desmaële D; Couvreur P
    Int J Pharm; 2016 Nov; 514(1):24-40. PubMed ID: 27863668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research advances in nanomedicine applied to the systemic treatment of colorectal cancer.
    Yin L; Li H; Shi L; Chen K; Pan H; Han W
    Int J Cancer; 2023 Mar; 152(5):807-821. PubMed ID: 35984398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer.
    Guo Y; Wang M; Zou Y; Jin L; Zhao Z; Liu Q; Wang S; Li J
    J Nanobiotechnology; 2022 Aug; 20(1):371. PubMed ID: 35953863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diatoms Green Nanotechnology for Biosilica-Based Drug Delivery Systems.
    Terracciano M; De Stefano L; Rea I
    Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30463290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer.
    Yang G; Cao Y; Yang X; Cui T; Tan NZV; Lim YK; Fu Y; Cao X; Bhandari A; Enikeev M; Efetov S; Balaban V; He M
    Exp Mol Pathol; 2024 Jun; 137():104904. PubMed ID: 38788248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
    Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
    Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Delivery through Epidermal Tissue Cells by Functionalized Biosilica from Diatom Microalgae.
    Vona D; Flemma A; Piccapane F; Cotugno P; Cicco SR; Armenise V; Vicente-Garcia C; Giangregorio MM; Procino G; Ragni R
    Mar Drugs; 2023 Aug; 21(8):. PubMed ID: 37623719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review.
    Ali DS; Othman HO; Anwer ET
    Curr Pharm Biotechnol; 2023; 24(12):1554-1559. PubMed ID: 36733239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of nanoscale drug delivery systems for colorectal cancer liver metastasis.
    Hong Y; Rao Y
    Biomed Pharmacother; 2019 Jun; 114():108764. PubMed ID: 30901717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
    Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
    Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SERS Quantification of Galunisertib Delivery in Colorectal Cancer Cells by Plasmonic-Assisted Diatomite Nanoparticles.
    Managò S; Tramontano C; Delle Cave D; Chianese G; Zito G; De Stefano L; Terracciano M; Lonardo E; De Luca AC; Rea I
    Small; 2021 Aug; 17(34):e2101711. PubMed ID: 34302422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
    Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
    Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
    Wang K; Shen R; Meng T; Hu F; Yuan H
    Molecules; 2022 May; 27(9):. PubMed ID: 35566331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Toxicity Assessment of Hybrid Diatomite Nanovectors Using Hydra vulgaris as a Model System.
    Terracciano M; De Stefano L; Tortiglione C; Tino A; Rea I
    Adv Biosyst; 2019 Apr; 3(4):e1800247. PubMed ID: 32627433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome technologies towards colorectal cancer therapeutics.
    Sang R; Stratton B; Engel A; Deng W
    Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Armamentarium in Drug Delivery for Colorectal Cancer.
    Ali A; Akhtar J; Ahmad U; Basheer AS; Jaiswal N; Jahan A
    Crit Rev Ther Drug Carrier Syst; 2022; 40(1):1-48. PubMed ID: 36374840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.